Genetic factor in BCAA metabolism linked to type 2 diabetes and coronary artery disease risk

A genomic structural equation modeling study of genome-wide association studies analyzed data from 42,826 individuals of European and East Asian descent. The research aimed to understand the genetic influence of branched-chain amino acid metabolism on type 2 diabetes and coronary artery disease, independent of traditional risk factors like body mass index and circulating lipid levels.

The analysis identified a genetic factor influencing BCAA metabolism that operates independently of BMI and lipid levels. Using this factor, researchers created a cross-population polygenic score that showed associations with hemoglobin A1c levels, blood glucose, and the onset of both type 2 diabetes and coronary artery disease. The study did not report specific effect sizes, absolute numbers, p-values, or confidence intervals for these associations.

No safety or tolerability data were reported as this was a genetic modeling study rather than an interventional trial. The findings represent early genetic insights into how BCAA metabolism might influence cardiometabolic disease risk beyond traditional factors. However, the study's practice relevance is limited as it describes associations rather than causation and lacks clinical effect size data that would inform patient management decisions.